Clippings

Second-ever pre-exposure prophylaxis study reports no safety concerns and promising result

Date: 23-07-2010

The last day of the Vienna International AIDS Conference featured the results of the second-ever completed randomised controlled trial of pre-exposure prophylaxis (PrEP) – giving antiretrovirals to HIV-negative people at high risk of HIV to prevent them becoming infected. The trial, which randomised 400 gay men to take either a daily tenofovir (Viread) or a

Click here to read full story provided by NAM

Go back to clippings list.